Abstract: A method for coating catheter balloons with a defined amount of a pharmacologically active agent, uses a coating device having a volume measuring device for releasing a measurable amount of a coating solution by means of a dispensing device specifically onto the surface of the catheter balloon.

Abstract: The invention relates to a data transmission device for transmitting data between a first bus system and a second bus system with a copy table (103) for providing an output sequence of data of the first bus system and a transmission device (101) for transmitting data between the first bus system and the second bus system according to the output sequence.

Abstract: The invention relates to a testing device for tube bundle reactors, with a multitude of tubes (22) arranged as a bundle. At least one probe (12) is movably mounted in or on the testing device (10) and has, in particular, a drive (32) for its movement.

Abstract: The present invention is directed to a method for coating catheter balloons with a defined amount of a pharmacologically active agent, wherein the coating method uses a coating device having a volume measuring device for releasing a measurable amount of a coating solution by means of a dispensing device specifically onto the surface of the catheter balloon.

Abstract: The present invention relates to in vitro cultured skin substitutes, and in particular to in vitro cultured skin substitutes that have improved barrier function. In some embodiments, improved barrier function is a result of improved culture conditions, while in other embodiments, improved barrier function results from genetic modification of keratinocytes. Improved culture conditions to improve barrier function include organotypic culture in the presence of linoleic acid and/or linoleic acid at about 75% humidity. Suitable genetic modifications for improving barrier function includes transfection with a DNA construct capable of expressing GKLF.

Abstract: In an injection system having a device for metering fuel into an exhaust system of a Diesel engine, and a method for controlling the injection of fuel into the exhaust system, wherein the injection system has a high-pressure pump which feeds fuel to an accumulator under high pressure and injectors which inject fuel from the accumulator into the combustion chambers of the internal combustion engine, a fuel spray nozzle arranged in the exhaust system is in communication with the injection system via a fuel metering unit including a control valve and a metering valve and a pressure regulating valve is arranged between the control valve and the metering valve for controlling the pressure of the fuel being metered by the metering valve for injection into the exhaust system via the spray nozzle.

Abstract: The present invention relates to in vitro cultured skin tissue, and in particular to cultured skin tissue comprising exogenous genes encoding angiogenic growth factors. In some embodiments, the keratinocytes express exogenous angiopoietin-1 or a member of the VEGF family, preferably VEGF-A. In particularly preferred embodiments, the keratinocytes are incorporated into cultured skin tissue.

Abstract: A process and a device for pushing hollow glass objects off a glass forming machine onto a moving conveyor belt are disclosed. Each hollow glass object is pushed by a push-off unit from a dead plate along a curved path onto the conveyor belt in such a way that the curved path is brought tangentially to a contact point in a movement direction of the conveyor belt. Subsequent to the contact point each hollow glass object is pushed further by the push-off unit by a further linear path portion in the movement direction of the conveyor belt as far as a release point at which the push-off unit is released from the hollow glass object. The push-off unit is then moved back to dead plate.

Abstract: The invention relates to a bus coupler which converts a network-specific telegram arriving from an external network to an internal data telegram which transmits only the payload data from the network-specific telegram. The internal data telegram also contains at least one state information field for internal control information. The internal data telegram is transferred from the bus coupler to an internal bus system to which multiple bus users are connected in series. Each bus user connected to the internal bus system is able to monitor, in a decentralized and preferably autonomous manner, the communication quality of the lower-level bus system, and to initiate actions, depending on the implementation, on the basis of the internal control information received from the bus coupler, the internal control information generated by the particular bus user, and/or the internal control information received from the directly adjacent bus users.

Abstract: A charging device for a tube reactor has a plurality of metering chambers which can be filled with filling material, for example a catalytically coated carrier material. Each metering chamber is adjoined by a drop tube or some other filling device via which a tube of the filling device can be filled in each case. The metering chambers can each be filled via antechambers which are combined into one replaceable antechamber unit.

Abstract: The invention concerns oligosaccharides and polysaccharides as well as the use of these oligosaccharides and/or polysaccharides, which contain the sugar unit N-acylglucosamine or N-acylgalactosamine for the production of hemocompatible surfaces as well as methods for the hemocompatible coating of surfaces with said oligosaccharides and/or polysaccharides, which imitate the common biosynthetic precursor substance of heparin, heparan sulphates and chitosan. The invention further describes methods for producing said oligosaccharides and/or polysaccharides and discloses various possibilities of using hemocompatibly coated surfaces. The invention relates particularly to the use of said oligosaccharides and/or polysaccharides on stents with at least one according to invention deposited hemocompatible coating, which contains an antiproliferative, antiinflammatory and/or antithrombotic active agent, methods for the preparation of said stents as well as the use of said stents for the prevention of restenosis.

Abstract: The invention pertains to a modular data transmission system with several modules or bus nodes that can be arranged adjacent to one another in a row. The data transmission system comprises a first bus node that features a first transmitter for the wireless transmission of data and an electrical connector, as well as a second bus node that features a first receiver for the wireless reception of data and an electrical connector. Both bus nodes are detachably fixed on a mounting rail such that they are arranged adjacent to one another in a row. The first and second bus nodes are respectively detachably connected to a bus receptacle, wherein each bus receptacle features an electrical mating connector that is coupled to the electrical connector of the respective bus node in the connected state in order to transmit energy, as well as a positioning device for positioning the respective bus node.

Abstract: An adsorbent for whole blood in the form of essentially spherical non-aggregated particles. The adsorbent comprises a porous carrier material having an average pore size of ?1.5 ?m, whereby a maximum of 50% of the pore volume may be in pores having a pore size of >1.5 ?m, whereby the outer surfaces of the porous carrier material have at least one surface modification M1 so that the outer surface essentially does not interact with blood cells, and the inner surfaces of the porous carrier material, e.g., the surfaces of the pores of the porous carrier material, have at least one surface modification M2 which interacts with substances present in blood.

Abstract: A method is disclosed in which data is exchanged via a bus coupler (500) between a network (410) designed for transmitting Ethernet telegrams and a lower-level bus system (420), wherein the bus coupler (500) is connected via a first interface (520) to the network (410) and via a second interface (530) to the lower-level bus system (420), and wherein process data is read in and/or output through at least one bus node (610, 620, 630) of the lower-level bus system (420). Furthermore, a bus coupler (500), a bus node (610, 620, 630), and a control system (10) that are designed for execution of the method are disclosed.

Abstract: A method for coating catheter balloons with a defined amount of a pharmacologically active agent, uses a coating device having a volume measuring device for releasing a measurable amount of a coating solution by means of a dispensing device specifically onto the surface of the catheter balloon.

Abstract: Software is disclosed that creates a way of controlling alterations to cell contents of a data flow network so they can easily be turned on and off as separate layers. These layers can then be grouped as scenarios. Scenarios allow different layers of formula changes to be easily added and removed from the model.

Abstract: The present invention relates to in vitro cultured skin substitutes, and in particular to in vitro cultured skin substitutes that have improved barrier function. In some embodiments, improved barrier function is a result of improved culture conditions, while in other embodiments, improved barrier function results from genetic modification of keratinocytes. Improved culture conditions to improve barrier function include organotypic culture in the presence of linoleic acid and/or linoleic acid at about 75% humidity. Suitable genetic modifications for improving barrier function includes transfection with a DNA construct capable of expressing GKLF.

Abstract: The embodiments described herein are directed to biodegradable stents comprising an inner biodegradable metal scaffold and an outer polymeric coating. The biodegradable coating consists preferentially of biodegradable polymers and may additionally include at least one pharmacologically active substance such as an anti-inflammatory, cytostatic, cytotoxic, antiproliferative, anti-microtubuli, antiangiogenic, antirestenotic (anti-restenosis), antifungicide, antineoplastic, antimigrative, athrombogenic and/or antithrombogenic agent.

Abstract: The invention relates to stents and catheter balloons having optimized coatings for eluting rapamycin as well as methods for manufacturing these coatings.

Abstract: Software is disclosed that creates a way of controlling alterations to cell contents of a data flow network so they can easily be turned on and off as separate layers. These layers can then be grouped as scenarios. Scenarios allow different layers of formula changes to be easily added and removed from the model.